Drug companies will be banned from applying for five years for one more drug

In the future, the enterprise applicants who apply for new drug batch number more than one drug will face the punishment of not applying for new drug and exposing it within 5 years On June 28, Liaoning Province held the conference on rectifying and standardizing the order of food and drug market and controlling commercial bribery The provincial drug regulatory department will clean up the drug market in half a year, and comprehensively rectify the situation of more than one drug Statistics from the provincial food and Drug Administration show that in the first half of this year, more than 300 "new drugs" in Liaoning Province required to apply for drug batch numbers, and at least 30% of them had problems in drug imitation and other aspects, and these "new drugs" with more than one drug suspect would not be approved China's overall level of biopharmaceutical industry lags behind that of Europe and the United States However, the U.S drug regulatory authorities only approved 150 drugs last year, while China approved more than 10000 drugs A drug regulatory official said that the proliferation of "new drugs" is mostly due to the countermeasures that pharmaceutical enterprises have come up with in response to the state's demand for drug price reduction, in order to seek the opportunity of falsely high pricing and profiteering Yu Bo, director of the provincial food and drug administration, said that the drug regulatory authorities will comprehensively crack down on illegal acts including "more than one drug" Drug registration applicants who report new drug batch numbers through fraud and irregularities will not be allowed to report new drugs within five years and report to the State Food and Drug Administration for recording bad records, but will also be punished by Media exposure The half year rectification campaign will focus on supervision and inspection of products such as hydrogel, Bologna care solution, beauty silk and other products banned by the state, and will also strictly investigate violations of blood products, biological agents and vaccine products At the same time, drug stores will lease the counter to individuals to sell drugs, as well as drug sales units that make false publicity in the community, which will be severely hit by the drug regulatory department The units and individuals that make use of "more than one drug" to seek interests or even engage in commercial bribery will face the revocation of their production licenses and corresponding criminal liabilities At the same day's meeting, the relevant person in charge of the provincial food and Drug Administration pointed out that there are 252 drug manufacturers in Liaoning Province, generally with small scale and low profit At present, the distribution right of common new drugs in Europe and America has reached more than 200 million US dollars, while the cost of developing a common drug in China is only about 20 million yuan, with huge profits The provincial government will invest 15 million yuan from this year to support biopharmaceutical projects and strive to support 8 to 10 varieties of new drugs in 10 years to earn foreign exchange Multi unit cooperation and joint research and development of biological drugs will become an important direction for the future development of the pharmaceutical industry in our province.